Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $32,657 | $0 | $0 | $0 |
Gross Profit | 31,961 | |||
EBITDA | -2,830 | -41,908 | -55,248 | -78,835 |
EBIT | -3,332 | -42,412 | -55,751 | -79,335 |
Net Income | -4,708 | -43,773 | -55,982 | -76,616 |
Net Change In Cash | 32,657 | 0 | 0 | 0 |
Free Cash Flow | -12,617 | -32,757 | -23,999 | -15,117 |
Cash | 76,497 | 81,331 | 87,928 | 48,413 |
Basic Shares | 50,483 | 46,179 | 43,925 | 41,879 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,958 | -2,210 | -2,207 | |
EBITDA | -173,632 | -37,030 | -21,857 | -28,703 |
EBIT | -184,429 | -38,988 | -24,067 | -30,910 |
Net Income | -175,850 | -38,988 | -20,319 | -29,561 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -69,314 | -24,940 | -20,794 | -27,792 |
Cash | 87,928 | 169,681 | 14,602 | 21,304 |
Basic Shares | 40,176 | 16,492 | 8,397 | 5,318 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.95 |
2024-12-31 | -$1.27 |
